Luminii provides CDD to Foresight on their recent investment into private healthcare company 352 Medical Group
Luminii Consulting is delighted to have provided Commercial Due Diligence (CDD) support to Foresight on their recent £5 million growth capital investment into Northern Ireland’s largest private healthcare business, 352 Medical Group Limited (“3fivetwo”).
The investment was made via a new fund managed by Foresight in partnership with 57 Stars, dedicated to investing in businesses with the potential to boost the economy of Northern Ireland.
The Company comprises principally of two private hospitals located in Belfast in Northern Ireland and Sligo in the Republic of Ireland. Founded in 2004 by NHS Consultant Obstetrician and Gynaecologist, Suresh Tharma, 3fivetwo began by providing services such as health screening, 3D obstetrics and gynaecology scanning. Since then the Company has grown significantly, first and foremost as a service provider for private patients and also as a provider of clinical outsourcing to the NHS.
The investment from Foresight will be used to increase theatre and ward capacity at both facilities, with a conversion of the theatres and a bed extension to the main wards planned to commence in 2019.
"Luminii Consulting is delighted to have supported Foresight on this transaction, this deal helps to further strengthen our credentials in the healthcare sector. We wish Foresight and 3fivetwo's Management team continued success for the future." - Lushani Kodituwakku, Managing Director, Luminii Consulting
Latest articles
- Luminii provides Vendor Commercial Due Diligence to Osprey Flight Solutions 08 Sep 2025
- Luminii provides CDD support to Agathos on their investment in Enfuse Group 24 Jun 2025
- Luminii provides CDD support to BGF on their investment in PMC 17 Jun 2025
- Luminii provides CDD support to 57 Stars on their investment in New Life Teeth 28 Mar 2025
- Luminii provides CDD support to Maven on their investment in Blackdot Solutions 07 Feb 2025






























